The profile is currenly unclaimed by the seller. All information is provided by CB Insights.

allegrodx.com

Founded Year

2006

Stage

Acquired | Acquired

Total Raised

$9.92M

Valuation

$0000 

About Allegro Diagnostics

Allegro Diagnostics is a molecular diagnostics company focused on the development and commercialization of genomic tests to support the diagnosis and management of lung cancer. These tests have the potential to enable the early diagnosis, staging and informed treatment of lung cancer and other lung diseases.

Allegro Diagnostics Headquarters Location

650 Albany Street

Boston, Massachusetts, 02118,

United States

617-414-6990

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Expert Collections containing Allegro Diagnostics

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Allegro Diagnostics is included in 2 Expert Collections, including Cancer.

C

Cancer

3,605 items

Companies researching, developing, or offering products & services that aid in the screening, prevention, diagnosis, management, and treatment of cancer.

O

Omics

1,267 items

Companies involved in the capture, sequencing, and/or analysis of genomic, transcriptomic, proteomic, and/or metabolomic data

Allegro Diagnostics Patents

Allegro Diagnostics has filed 3 patents.

patents chart

Application Date

Grant Date

Title

Related Topics

Status

3/13/2014

1/7/2020

Glucocorticoids, Muscarinic antagonists, Pregnanes, Diketones, Beta blockers

Grant

Application Date

3/13/2014

Grant Date

1/7/2020

Title

Related Topics

Glucocorticoids, Muscarinic antagonists, Pregnanes, Diketones, Beta blockers

Status

Grant

Latest Allegro Diagnostics News

Veracyte Acquires Allegro Diagnostics for Lung Cancer Test Technology

Sep 5, 2014

VentureWire , September 04, 2014, (c) 2014 Dow Jones & Company, Inc. Publicly traded Veracyte Inc., a molecular diagnostics company working in the field of molecular cytology, announced an agreement to acquire Allegro Diagnostics Corp. for $21 million. Veracyte said it will pay $7.8 million in cash and $13.2 million in common stock.... Document DJFVW00120140904ea94tn6s5 To continue reading this story login at the top right or try the product Document DJFVW00120140904ea94tn6s5 Exclusive news and deep analysis of what’s really happening with venture capital-backed companies, their investors,and their management teams.

  • When was Allegro Diagnostics founded?

    Allegro Diagnostics was founded in 2006.

  • Where is Allegro Diagnostics's headquarters?

    Allegro Diagnostics's headquarters is located at 650 Albany Street, Boston.

  • What is Allegro Diagnostics's latest funding round?

    Allegro Diagnostics's latest funding round is Acquired.

  • How much did Allegro Diagnostics raise?

    Allegro Diagnostics raised a total of $9.92M.

  • Who are the investors of Allegro Diagnostics?

    Investors of Allegro Diagnostics include Veracyte, Kodiak Venture Partners, Catalyst Health Ventures, Qualifying Therapeutic Discovery Project, Small Business Innovation Research Awards and 5 more.

  • Who are Allegro Diagnostics's competitors?

    Competitors of Allegro Diagnostics include Dilon Technologies, Biodesix, Upromise, AutoGenomics, Integrated Diagnostics and 15 more.

You May Also Like

A
AngioLogix

AngioLogix is a provider of cardiovascular health diagnostics.

D
Dilon Technologies

Dilon Technologies delivers clinically useful imaging and intra operative systems appropriate for early disease diagnosis and surgical applications. Dilon's cornerstone product, the Dilon Molecular Breast Imaging System, is a high-resolution, compact camera, and is available as a single or dual head camera. The Dilon cameras have been optimized to perform Molecular Breast Imaging (MBI/BSGI) procedure that aids in early detection of breast cancer.

N
Nanogen Adavanced Diagnostics S.r.l.

At Nanogen, Inc., the company develop diagnostic products that enable physicians to deliver improved patient care. The company's products allow faster and easier diagnosis, treatment and monitoring of cardiovascular disease and infectious diseases. These products include molecular diagnostic kits and reagents, and rapid test kits, which can be used in urgent care settings or at the point-of-care. Nanogen has pioneered developments in areas involving biomarkers, molecular biology and nanotechnology. The company's business focus is to bring better results to diagnostics and healthcare.

P
ProteoGenix

ProteoGenix offers maternal-fetal diagnostics

H
Hx Diagnostics

Hx Diagnostics offers rapid diagnostics for seasonal and emerging infectious diseases.

Akonni Biosystems Logo
Akonni Biosystems

Akonni Biosystems is a molecular diagnostics (MDx) company that develops, manufactures, and markets integrated molecular diagnostic systems.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.